MedTech News
Precision therapy could stop breast cancer at the source
Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in lung cancer. The approach restores drug sensitivity and slows tumor growth. The findings are published in the journal Molecular Therapy Oncology.
Gene ‘switch’ reverses Alzheimer’s risk in experimental model
University of Kentucky researchers have developed a new experimental model that could point the way toward more effective Alzheimer’s disease treatments by targeting one of the brain’s most important genes for risk and resilience.
Zavation Medical Products Announces First Implantations of Varisync® ALIF NanoPrime™
FLOWOOD, Miss., Nov. 15, 2025 /PRNewswire/ — Zavation Medical Products, LLC (“Zavation”), a leading innovator in spinal device technology, announces the first successful implantations of the Varisync® ALIF NanoPrime™ System, a next-generation stand-alone ALIF system featuring Zavation’s proprietary titanium ion bond technology.
Avicenna.AI Launches AVI Seamless Platform for Medical Imaging AI
New platform is designed to enable fast, scalable access to a wide range of AI imaging solutions
FDA grants label expansion for BrainsWay Deep TMS to treat MDD
The clearance is based on data that included real-world evidence from 1,120 adolescents who received treatment at US TMS centres.
Renu MedTech introduces tubeless insulin patch pump in India
Renu MedTech today unveiled InsuPatch, its tubeless insulin patch pump designed specifically for advancing diabetes care in India.
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology
WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ROSA® Knee with OptimiZe™, an enhanced version of its ROSA® Knee System that offers a more customized experience for surgeons to help deliver accurate and reproducible outcomes1 in robotic-assisted total knee replacement surgery.